Attached files
| file | filename |
|---|---|
| EX-31.1 - EXHIBIT 31.1 CERTIFICATION - PROGENICS PHARMACEUTICALS INC | ex31_112312010.htm |
| EX-32.2 - EXHIBIT 32.2 CERTIFICATION - PROGENICS PHARMACEUTICALS INC | ex32_212312010.htm |
| EX-32.1 - EXHIBIT 32.1 CERTIFICATION - PROGENICS PHARMACEUTICALS INC | ex32_112312010.htm |
| EX-10.37 - EXHIBIT 10.37 PROGENICS - PROGENICS PHARMACEUTICALS INC | ex10_3712312010.htm |
| EX-31.2 - EXHIBIT 31.2 CERTIFICATION - PROGENICS PHARMACEUTICALS INC | ex31_212312010.htm |
| 10-K - PROGENICS FORM 10-K DECEMBER 31, 2010 - PROGENICS PHARMACEUTICALS INC | form10_k12312010.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statements on Form S-8 (Nos. 333-52277, 333-120508, 333-124910, 333-143670, 333-160389, 333-160392, 333-168124) of Progenics Pharmaceuticals, Inc. of our report dated March 11, 2011 relating to the financial statements, and the effectiveness of internal control over financial reporting, which appears in this Form 10-K.
|
/s/ PricewaterhouseCoopers LLP
|
|
|
New York, New York
|
|
|
March 11, 2011
|